全经皮入路与开放股动脉暴露在EVAR中的安全性和有效性比较:一项Meta分析
该Meta分析纳入11项研究共1650例患者2500个腹股沟入路,比较全经皮入路(PEVAR)与开放股动脉暴露(OFA)在EVAR中的安全性和有效性。结果显示PEVAR技术成功率与OFA无显著差异,但手术时间更短且总并发症率更低。
要点
- PEVAR技术成功率94.5%,与OFA无显著差异(OR 0.38,95%CI 0.12-1.18,p=0.09)。
- PEVAR手术时间显著短于OFA(平均差-24.52,95%CI -46.45至-22.60,p<0.001)。
- PEVAR总并发症率7.8%显著低于OFA的15.3%(OR 0.52,95%CI 0.37-0.73,p<0.001)。
核心结论
- PEVAR与OFA技术成功率相似,但PEVAR手术时间更短且并发症率更低,经皮入路似乎是EVAR的首选方法。
研究设计与样本
- 系统检索1999年1月至2016年8月Medline、EMBASE和Cochrane数据库的英文文献,纳入11项研究共1650例患者2500个腹股沟入路。
- 采用Newcastle-Ottawa量表评价个体研究质量,数据以OR或MD及95%CI汇总。
主要发现
- PEVAR组平均技术成功率为94.5%(785/831),总体OR为0.38(95%CI 0.12-1.18,p=0.09),两组间无显著差异。
- PEVAR手术时间短于OFA(平均差-24.52,95%CI -46.45至-22.60,p<0.001)。
- OFA组总并发症率为15.3%,PEVAR组为7.8%(OR 0.52,95%CI 0.37-0.73,p<0.001)。
- 伤口感染(OR 0.28,95%CI 0.10-0.81,p=0.02)、血清肿(OR 0.10,95%CI 0.02-0.55,p=0.008)、淋巴囊肿或淋巴漏(OR 0.19,95%CI 0.04-0.92,p=0.04)在PEVAR组更低。
- 假性动脉瘤在PEVAR组更高(OR 8.07,95%CI 1.54-42.32,p=0.01)。
临床怎么用
- 对于适合经皮入路的EVAR患者,PEVAR可缩短手术时间并降低总并发症率,可作为优先考虑的入路方式。
- 需警惕PEVAR相关的假性动脉瘤风险,而OFA则需注意伤口感染、血清肿和淋巴漏等并发症。
局限性
- 需要更大规模和随机对照研究才能得出确定性结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the safety and efficacy of percutaneous (PEVAR) vs open femoral access (OFA) techniques for endovascular aneurysm repair (EVAR). METHODS: A systematic review of English-language articles (Medline, EMBASE, and Cochrane databases) between January 1999 and August 2016 returned 11 studies including 1650 patients with 2500 groin accesses eligible for the meta-analysis. Data extracted from each study were synthesized to evaluate technical success rates, procedure time, and complications for the 2 access approaches. Data are presented as the odds ratio (OR) or mean difference (MD) with 95% confidence intervals (CI). The quality of individual studies was evaluated based on the Newcastle-Ottawa scale. RESULTS: The mean technical success rate in the PEVAR group was 94.5% (785/831). The overall OR was 0.38 (95% CI 0.12 to 1.18, p=0.09), indicating no significant difference between the methods. The procedure time in PEVAR was shorter than OFA (mean difference -24.52, 95% CI -46.45 to -22.60, p<0.001). Overall, the total complication rate was 15.3% in the OFA group vs 7.8% in the PEVAR group (OR 0.52, 95% CI 0.37 to 0.73, p<0.001). The meta-analysis identified significant differences between groups for all complications (p<0.001) and the following individual adverse events: wound infection (OR 0.28, 95% CI 0.10 to 0.81, p=0.02), pseudoaneurysm (OR 8.07, 95% CI 1.54 to 42.32, p=0.01), seroma (OR 0.10, 95% CI 0.02 to 0.55, p=0.008), and lymphocele or lymph leak (OR 0.19, 95% CI 0.04 to 0.92, p=0.04). CONCLUSION: PEVAR had a similar technical success rate, shorter procedure time, and lower complication rate compared with OFA. Thus, percutaneous access appears to be the preferential approach for EVAR. However, larger and randomized studies are needed to draw definitive conclusions.
引用
- Cao Z, Wu W, Zhao K, et al. Safety and Efficacy of Totally Percutaneous Access Compared With Open Femoral Exposure for Endovascular Aneurysm Repair: A Meta-analysis. J Endovasc Ther. 2017. PMID: 28164730. doi:10.1177/1526602816689679
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。